Eclampsia
📧 Sign up to get email alerts when something new happens for Eclampsia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-06-09Clinical Trial Update: Improved Accessibility of EmONC Services for Maternal and Newborn Health: a Community Based Project [NA]
A community-based trial update from Aga Khan University describes a completed project aimed at improving access to emergency obstetric and n…
-
CLINICAL_TRIALS trial_result · 2016-05-26Clinical Trial Update: Eclampsia and Posterior Reversible Encephalopathy Syndrome (PRES): [NA]
The clinical trial NCT02027272 studying eclampsia and posterior reversible encephalopathy syndrome (PRES) was terminated and results were po…
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Hypertensive and Normal Pregnancy--Calcium Metabolism and Renin-Angiotensin - SCOR in Hypertension
Completed NHLBI-sponsored clinical trial update examining calcium metabolism and the renin-angiotensin system in hypertensive and normal pre…
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Evaluation of a Physical Therapy Protocol on Quality of Life Musculoskeletal Pain and Anxiety in Women With Preeclampsia
A completed clinical trial evaluated whether a physical therapy protocol improves quality of life, musculoskeletal pain, and anxiety in wome…
-
FDA approval · 2016-03-02FDA Approved: MAGNESIUM SULFATE IN DEXTROSE — Original Application (WG Critical Care, LLC)
FDA approved a new original application for Magnesium Sulfate in Dextrose injection from WG Critical Care, LLC (ANDA 207349).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-02-29FDA Approved: MAGNESIUM SULFATE — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for Magnesium Sulfate Heptahydrate from Fresenius Kabi USA, LLC, updating the product's approval…
-
FDA approval · 2015-07-14FDA Approved: MAGNESIUM SULFATE IN DEXTROSE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for MAGNESIUM SULFATE IN DEXTROSE from Hospira, Inc., effectively updating the NDA for this product.
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Randomized Study of Nimodipine Versus Magnesium Sulfate in the Prevention of Eclamptic Seizures in Patients With Severe Preeclampsia [NA]
This document reports the completion of a randomized trial comparing nimodipine to magnesium sulfate to prevent eclamptic seizures in women …
-
CLINICAL_TRIALS trial_result · 2015-01-28Clinical Trial Update: A Skills and Drills Intervention for Emergency Obstetrics and Neonatal Care at First Referral Units of North Karnataka [NA]
This clinical trial evaluated a skills and drills training intervention to improve emergency obstetric and neonatal care at first referral u…
-
CLINICAL_TRIALS research · 2014-10-06Clinical Trial Update: uChek Pilot Study for Urinalysis in the Antenatal Care Setting
Clinical trial update for the uChek Pilot Study evaluating urinalysis in antenatal care. The current status is unknown.
-
CLINICAL_TRIALS trial_result · 2014-04-28Clinical Trial Update: Assessing Childbirth-related Complications at the Community Level in Kenya
A completed Kenyan community-level clinical trial evaluated childbirth-related complications, including puerperal sepsis, postpartum hemorrh…
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: The Effect of neutrophil-to Lymphocyte Ratio in Preeclampsia- Eclampsia
This clinical trial update discusses the potential role of the neutrophil-to-lymphocyte ratio in preeclampsia and eclampsia.
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: RCT of Antioxidant Therapy to Prevent Preeclampsia in Brazil [Phase 3]
A Phase 3 randomized trial in Brazil evaluating antioxidant therapy to prevent preeclampsia during pregnancy has completed.
-
FDA label_change · 2012-12-17FDA Approved: MAGNESIUM SULFATE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for magnesium sulfate from Hospira, Inc., resulting in changes to the product labeling.